Generation of high-affinity recombinant antibodies for application in Immuno-MRM
Monoclonal antibodies are essential for the peptide immunoaffinity enrichment step prior to multiple reaction monitoring-mass spectrometry (MRM-MS) assays. But anti-peptide antibody generation using traditional mouse hybridoma methods has limitations, such as long timelines, uncertain success rates and the inability to control selection parameters such as affinity.
We collaborated with scientists at the Fred Hutchinson Cancer Research Center to carry out a feasibility study to discover whether recombinant anti-peptide antibodies generated using the HuCAL® antibody library and phage display technology are suitable for immunoaffinity enrichment of peptides coupled to targeted MRM.
Presented by: Dr Christian Frisch (R&D Manager Custom Antibodies, Bio-Rad AbD Serotec GmbH)
Speaker Biography: Dr Christian Frisch (R&D Manager Custom Antibodies)
Christian Frisch is R&D manager at Bio-Rad and heads the antibody generation group since 2003. He studied Molecular Biology in Göttingen (Germany) and did his Ph.D. with Prof. Alan Fersht at the University of Cambridge (UK) working on the energetics of protein-protein interactions and protein folding. In 1997 he joined MorphoSys AG, working on the development of display technologies and the generation of antibody phage display libraries. His group at Bio-Rad generated more than 20,000 antibodies in over 1,000 custom projects over the last 10 years.
Toll Free: +1 800 265 7376
Tel: +1 919 878 7978
Tel: +49 89 80 90 95 21
Tel: +44 1865 852 700
To discuss a custom HuCAL antibody generation project, contact
Tel: +49 89 80 90 95 45
Or complete our online inquiry form
HuCAL® is a registered trademark of MorphoSys AG.
Payment methods we support: